In Defense of Baseline Genotypic Antiretroviral Resistance Testing

被引：2
|
作者：
Lang, Raynell [1 ]
Krentz, Hartmut B. [2 ]
Gill, M. John [3 ]
机构：
[1] Univ Calgary, Dept Med, Calgary, AB, Canada
[2] S Alberta HIV Clin Calgary, Calgary, AB, Canada
[3] Univ Calgary, Dept Med, S Alberta HIV Clin Calgary, Calgary, AB, Canada
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2020年 / 83卷 / 01期
关键词：
DRUG-RESISTANCE; PREVALENCE; THERAPY; COST;
D O I：
10.1097/QAI.0000000000002210
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E1 / E2
页数：2
相关论文
共 50 条
  • [41] Quality control assessment for HIV-1 genotypic antiretroviral testing (2002)
    Brun-Vézinet, F
    Masquelier, B
    Izopet, J
    Calvez, V
    Chaix, ML
    Ruffault, A
    Tamalet, C
    Yerly, S
    Descamps, D
    Costagliola, D
    [J]. ANTIVIRAL THERAPY, 2003, 8 (03) : U91 - U91
  • [42] The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach
    Yazdanpanah, Y.
    Vray, M.
    Meynard, J.
    Losina, E.
    Weinstein, M. C.
    Morand-Joubert, L.
    Goldie, S. J.
    Hsu, H. E.
    Walensky, R. P.
    Dalban, C.
    Sax, Pe
    Girard, Pm
    Freedberg, Ka
    [J]. HIV MEDICINE, 2007, 8 (07) : 439 - 450
  • [43] The role of genotypic resistance testing in selecting therapy for HIV
    Pèrez-Molina, JA
    Fernández, RA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (13): : 1649 - 1650
  • [44] Genotypic resistance testing in HIV by arrayed primer extension
    Michaela Schanné
    Jochen Bodem
    Aslihan Gerhold-Ay
    Anette Jacob
    Kurt Fellenberg
    Hans-Georg Kräusslich
    Jörg D. Hoheisel
    [J]. Analytical and Bioanalytical Chemistry, 2008, 391 : 1661 - 1669
  • [45] Genotypic resistance testing in HIV by arrayed primer extension
    Schanne, Michaela
    Bodem, Jochen
    Gerhold-Ay, Aslihan
    Jacob, Anette
    Fellenberg, Kurt
    Kraesslich, Hans-Georg
    Hoheisel, Joerg D.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 391 (05) : 1661 - 1669
  • [46] Increased uptake of early initiation of antiretroviral therapy and baseline drug resistance testing in San Francisco between 2001 and 2015
    Truong, Hong-Ha M.
    Pipkin, Sharon
    Grant, Robert M.
    Liegler, Teri
    O'Keefe, Kara J.
    Scheer, Susan
    [J]. PLOS ONE, 2019, 14 (03):
  • [47] Study of different systems for interpreting results of genotypic antiretroviral drug resistance tests
    García, F
    Palomares, JC
    Martínez, NM
    Alvarez, M
    Suarez, S
    García, F
    Rodríguez, JM
    Quero, JH
    Maroto, MD
    [J]. ANTIVIRAL THERAPY, 2003, 8 (03) : 251 - 252
  • [48] HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization
    Kagan, R
    Winters, M
    Merigan, T
    Heseltine, P
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (01) : 1 - 9
  • [49] Interpretation of Genotypic Resistance to Predict Darunavir/Ritonavir Failure in Antiretroviral Experienced Patients
    Sterrantino, Gaetana
    Zaccarelli, Mauro
    Trotta, Michele
    De Luca, Andrea
    Borghi, Vanni
    Meraviglia, Paola
    Corsi, Paola
    Bonora, Stefano
    Leoncini, Francesco
    Zazzi, Maurizio
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (02) : 170 - 172
  • [50] Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid
    de Mendoza, C
    del Romero, J
    Rodríguez, C
    Corral, A
    Soriano, V
    [J]. AIDS, 2002, 16 (13) : 1830 - 1832
12345